Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Seres Therapeutics, Inc. (MCRB)
Last seres therapeutics, inc. earnings: 11/5 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.serestherapeutics.com
Company Research
Source: Yahoo! Finance
Seres Therapeutics, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details here Operator: Thank you for standing by. My name is Alex, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q1 2024 Seres Therapeutics Earnings Conference Call [Operator Instructions]. I would now like to turn the call over to Carlo Tanzi, Investor Relations. Please go ahead. Carlo Tanzi: Thank you, and good morning. Our press release for the company's first quarter 2024 financial results and business update became available at 7:00 a.m. Eastern Time this morning and can be found on the Investors and News section of the company's Web site. I'd like to remind you that we will be making forward-looking statements, including about the potential for VOWST, the timing and results of our clinical studies, future product candidates and development plans, our ability to generate additional capital, the suff
Show less
Read more
Impact Snapshot
Event Time:
MCRB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MCRB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MCRB alerts
High impacting Seres Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
MCRB
News
- Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Seres Therapeutics, Inc. (NASDAQ: MCRB) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc..MarketBeat
- Seres Therapeutics, Inc. (NASDAQ: MCRB) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $15.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023 [Yahoo! Finance]Yahoo! Finance
- Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023PR Newswire
MCRB
Earnings
- 5/8/24 - Beat
MCRB
Sec Filings
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- MCRB's page on the SEC website